Provided by Tiger Fintech (Singapore) Pte. Ltd.

Global Blood Therapeutics

68.49
0.0000
Volume:- -
Turnover:224.61M
Market Cap:4.62B
PE:-13.69
High:68.49
Open:68.49
Low:68.49
Close:68.49
52wk High:73.02
52wk Low:21.65
Shares:67.48M
Float Shares:58.58M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0019
EPS(LYR):-4.8138
ROE:-148.56%
ROA:-25.18%
PB:39.05
PE(LYR):-14.23

Loading ...

Aug 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 28, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Jun 28, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Jun 20, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 20, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 20, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 20, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 20, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 20, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 20, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 20, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 20, 2019

Major Issues Report

Current report, item 5.07
Jun 14, 2019

Major Issues Report

Current report, item 8.01
May 10, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 08, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Mar 29, 2019

[Rev.]Quaterly Report

[Amend] Quarterly report [Sections 13 or 15(d)]
Oct 25, 2016

Correspondence